Panacea Biotec Limited (NSE:PANACEABIO)

Panacea Biotec Revenue

Panacea Biotec had revenue of 2.00B INR in the quarter ending June 30, 2026, with 19.72% growth. This brings the company's total for the last twelve months to 6.73B, up 10.26% year-over-year. In the fiscal year ending March 31, 2026, Panacea Biotec had annual revenue of 6.40B with 14.43% growth. That makes Panacea Biotec the 25,306th largest company in the world by revenue and 1,561st in India.

• Revenue (ttm): 6.73B
• Revenue Growth: +10.26%
• P/S Ratio: 2.98
• Revenue / Employee: 3.20M
• Employees: 2,102
• Market Cap: 19.28B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Vaccines 4.10B 64.1%
• Pharmaceutical Formulations & Nutrition 2.30B 35.9%

By Geography

Chart

• Overseas 4.21B 65.9%
• India 2.18B 34.1%

Fiscal year ended Mar 31, 2026 See the full Panacea Biotec breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.40B	806.80M	14.43%
Mar 31, 2025	5.59B	-740.00K	-0.01%
Mar 31, 2024	5.59B	992.22M	21.57%
Mar 31, 2023	4.60B	-2.01B	-30.44%
Mar 31, 2022	6.61B	364.27M	5.83%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error